NEOGEN CORP (NEOG) Fundamental Analysis & Valuation

NASDAQ:NEOG • US6404911066

Current stock price

9.085 USD
-0.18 (-2%)
Last:

This NEOG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NEOG Profitability Analysis

1.1 Basic Checks

  • In the past year NEOG was profitable.
  • In the past year NEOG had a positive cash flow from operations.
  • In multiple years NEOG reported negative net income over the last 5 years.
  • In the past 5 years NEOG always reported a positive cash flow from operatings.
NEOG Yearly Net Income VS EBIT VS OCF VS FCFNEOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • NEOG's Return On Assets of -17.94% is in line compared to the rest of the industry. NEOG outperforms 52.17% of its industry peers.
  • With a Return On Equity value of -28.64%, NEOG perfoms like the industry average, outperforming 54.35% of the companies in the same industry.
Industry RankSector Rank
ROA -17.94%
ROE -28.64%
ROIC N/A
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
NEOG Yearly ROA, ROE, ROICNEOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • NEOG's Gross Margin of 45.98% is on the low side compared to the rest of the industry. NEOG is outperformed by 60.87% of its industry peers.
  • In the last couple of years the Gross Margin of NEOG has remained more or less at the same level.
  • NEOG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
NEOG Yearly Profit, Operating, Gross MarginsNEOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NEOG Health Analysis

2.1 Basic Checks

  • NEOG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NEOG has about the same amount of shares outstanding.
  • Compared to 5 years ago, NEOG has more shares outstanding
  • The debt/assets ratio for NEOG is higher compared to a year ago.
NEOG Yearly Shares OutstandingNEOG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NEOG Yearly Total Debt VS Total AssetsNEOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • NEOG has an Altman-Z score of 1.13. This is a bad value and indicates that NEOG is not financially healthy and even has some risk of bankruptcy.
  • NEOG has a Altman-Z score (1.13) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.38 indicates that NEOG is not too dependend on debt financing.
  • NEOG has a Debt to Equity ratio of 0.38. This is comparable to the rest of the industry: NEOG outperforms 47.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC10.31%
NEOG Yearly LT Debt VS Equity VS FCFNEOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 3.91 indicates that NEOG has no problem at all paying its short term obligations.
  • NEOG has a better Current ratio (3.91) than 65.76% of its industry peers.
  • A Quick Ratio of 2.80 indicates that NEOG has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.80, NEOG is doing good in the industry, outperforming 63.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 2.8
NEOG Yearly Current Assets VS Current LiabilitesNEOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NEOG Growth Analysis

3.1 Past

  • The earnings per share for NEOG have decreased strongly by -27.50% in the last year.
  • The earnings per share for NEOG have been decreasing by -10.20% on average. This is quite bad
  • Looking at the last year, NEOG shows a decrease in Revenue. The Revenue has decreased by -3.67% in the last year.
  • The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.5%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-9.09%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-2.84%

3.2 Future

  • NEOG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.29% yearly.
  • Based on estimates for the next years, NEOG will show a decrease in Revenue. The Revenue will decrease by -0.50% on average per year.
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue Next Year-4.55%
Revenue Next 2Y-1.49%
Revenue Next 3Y-0.67%
Revenue Next 5Y-0.5%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NEOG Yearly Revenue VS EstimatesNEOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
NEOG Yearly EPS VS EstimatesNEOG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. NEOG Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 31.33, NEOG can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, NEOG is valued a bit cheaper than the industry average as 72.83% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.11. NEOG is around the same levels.
  • The Price/Forward Earnings ratio is 26.79, which means the current valuation is very expensive for NEOG.
  • Based on the Price/Forward Earnings ratio, NEOG is valued a bit cheaper than 72.83% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of NEOG to the average of the S&P500 Index (24.12), we can say NEOG is valued inline with the index average.
Industry RankSector Rank
PE 31.33
Fwd PE 26.79
NEOG Price Earnings VS Forward Price EarningsNEOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NEOG indicates a somewhat cheap valuation: NEOG is cheaper than 69.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 30.17
NEOG Per share dataNEOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.38%
EPS Next 3Y9.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEOG Dividend Analysis

5.1 Amount

  • No dividends for NEOG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEOG Fundamentals: All Metrics, Ratios and Statistics

NEOGEN CORP

NASDAQ:NEOG (3/18/2026, 1:47:49 PM)

9.085

-0.18 (-2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-08
Earnings (Next)04-01
Inst Owners104.06%
Inst Owner Change-16.56%
Ins Owners0.65%
Ins Owner Change24.72%
Market Cap1.98B
Revenue(TTM)880.32M
Net Income(TTM)-602.74M
Analysts78.18
Price Target11.22 (23.5%)
Short Float %4.6%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)87.17%
Min EPS beat(2)78.25%
Max EPS beat(2)96.08%
EPS beat(4)2
Avg EPS beat(4)32.2%
Min EPS beat(4)-34.64%
Max EPS beat(4)96.08%
EPS beat(8)3
Avg EPS beat(8)11.3%
EPS beat(12)5
Avg EPS beat(12)119.18%
EPS beat(16)6
Avg EPS beat(16)37.27%
Revenue beat(2)2
Avg Revenue beat(2)3.22%
Min Revenue beat(2)0.46%
Max Revenue beat(2)5.99%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-3.66%
Max Revenue beat(4)5.99%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)4
Avg Revenue beat(12)-0.24%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)0%
PT rev (3m)44.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.69%
EPS NY rev (1m)0%
EPS NY rev (3m)22.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.31%
Valuation
Industry RankSector Rank
PE 31.33
Fwd PE 26.79
P/S 2.24
P/FCF N/A
P/OCF 29.85
P/B 0.94
P/tB N/A
EV/EBITDA 30.17
EPS(TTM)0.29
EY3.19%
EPS(NY)0.34
Fwd EY3.73%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.3
OCFY3.35%
SpS4.05
BVpS9.67
TBVpS-1.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.95
Profitability
Industry RankSector Rank
ROA -17.94%
ROE -28.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.98%
FCFM N/A
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 8.98
Cap/Depr 71.99%
Cap/Sales 9.62%
Interest Coverage N/A
Cash Conversion 74.97%
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 2.8
Altman-Z 1.13
F-Score4
WACC10.31%
ROIC/WACCN/A
Cap/Depr(3y)85.8%
Cap/Depr(5y)97.5%
Cap/Sales(3y)10.58%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.5%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-9.09%
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-2.84%
Revenue Next Year-4.55%
Revenue Next 2Y-1.49%
Revenue Next 3Y-0.67%
Revenue Next 5Y-0.5%
EBIT growth 1Y-193.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year138.34%
EBIT Next 3Y34.61%
EBIT Next 5Y20.01%
FCF growth 1Y-209.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.22%
OCF growth 3Y-5.05%
OCF growth 5Y-7.47%

NEOGEN CORP / NEOG Fundamental Analysis FAQ

What is the fundamental rating for NEOG stock?

ChartMill assigns a fundamental rating of 3 / 10 to NEOG.


What is the valuation status of NEOGEN CORP (NEOG) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEOGEN CORP (NEOG). This can be considered as Overvalued.


How profitable is NEOGEN CORP (NEOG) stock?

NEOGEN CORP (NEOG) has a profitability rating of 2 / 10.


What is the financial health of NEOGEN CORP (NEOG) stock?

The financial health rating of NEOGEN CORP (NEOG) is 4 / 10.


What is the expected EPS growth for NEOGEN CORP (NEOG) stock?

The Earnings per Share (EPS) of NEOGEN CORP (NEOG) is expected to decline by -9.33% in the next year.